Davern Capital Partners, LP
Source: SEC Form 13F · as of Mar 2026Davern Capital Partners, LP holds 16 biotech & pharma companies tracked by BioSniper, totaling $335.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$335.7M
| Company | Shares | Value |
|---|---|---|
| PFEPFIZER INC | 1,593,942 | $44.8M |
| REGNREGENERON PHARMACEUTICALS, INC. | 44,800 | $34.6M |
| INSMINSMED Inc | 182,562 | $29.9M |
| IONSIONIS PHARMACEUTICALS INC | 386,903 | $29.1M |
| BNTXBioNTech SE | 305,055 | $27.1M |
| ARGXARGENX SE | 35,045 | $25.6M |
| LLYELI LILLY & Co | 27,279 | $25.1M |
| RPRXRoyalty Pharma plc | 520,009 | $24.9M |
| ROIVRoivant Sciences Ltd. | 873,398 | $24.2M |
| LEGNLegend Biotech Corp | 1,314,748 | $23.8M |
| MLYSMineralys Therapeutics, Inc. | 447,153 | $12.1M |
| ABVXAbivax SA | 78,125 | $8.7M |
| GENBGenerate Biomedicines Inc. | 591,800 | $7.4M |
| PRCTPROCEPT BioRobotics Corporation | 261,200 | $6.5M |
| GPCRStructure Therapeutics Inc. | 126,461 | $6.1M |
| VRDNViridian Therapeutics, Inc.\DE | 302,457 | $5.9M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.